Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 5/20 | 0.76 |
| ▸ | SIGLEC7 | Q9Y286 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21555926 | 1.00 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL15087791 | 0.94 | CD22 (0.78) | CD22SIGLEC7 | |
| SCHEMBL15090098 | 0.94 | CD22 (0.78) | CD22SIGLEC7 | |
| SCHEMBL16372999 | 0.93 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL16839996 | 0.93 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL18357289 | 0.93 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL18083826 | 0.93 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL18083824 | 0.93 | CD22 (0.76) | CD22SIGLEC7 | |
| SCHEMBL16373002 | 0.92 | CD22 (0.83) | CD22SIGLEC7 | |
| SCHEMBL17715114 | 0.91 | CD22 (0.72) | CD22SIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160362436-A1 | SIALIC ACID DERIVATIVES | BROSSMER REINHARD (DE) | 2016-12-15 | — | — | US | disclosed |
| US-9260467-B2 | Sialic acid dimers | BROSSMER REINHARD (DE) | 2016-02-16 | — | — | US | disclosed |
| WO-2015128344-A1 | SIALIC ACID DERIVATIVES | BROSSMER REINHARD (DE) | 2015-09-03 | — | — | WO | disclosed |
| EP-2910561-A1 | Sialic acid derivatives | Brossmer, Reinhard (DE) | 2015-08-26 | — | — | EP | disclosed |
| US-20150005245-A1 | Sialic Acid Dimers | BROSSMER REINHARD (DE) | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362436-A1 | SIALIC ACID DERIVATIVES | NEU1, NEU2, NEU3 | CD22 83/4885SIGLEC7 7/4885 |
| US-20150005245-A1 | Sialic Acid Dimers | SIGLEC9, SIGLEC7, NEU2 | CD22 20/4885SIGLEC7 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.